Education

Fellowship
Hematology-Oncology, UCLA School of Medicine, 1982
Residency
Internal Medicine, University of Chicago Hospitals, 1979
Internship
Internal Medicine, University of Chicago Hospitals, 1976
Degree
MD, University of Chicago Pritzker School of Medicine, 1975

Medical Board Certifications

Medical Oncology
American Board of Internal Medicine, 1981
Internal Medicine
American Board of Internal Medicine, 1978

Gender

Male

State License

G39056
  • About Me

    About Me

    Dennis J. Slamon, M.D., Ph.D., serves as director of Clinical/Translational Research, and as director of the Revlon/UCLA Women's Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA's Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer.

    For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients. To acknowledge Slamon's accomplishments, President Clinton appointed Slamon to the three-member President's Cancer Panel in June 2000.

    A 1975 honors graduate of the University of Chicago's Pritzker School of Medicine, Slamon earned his Ph.D. in cell biology that same year. He completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, he became a fellow in the Division of Hematology/Oncology at UCLA.

    Links

  • Education

    Medical Board Certifications

    Medical Oncology
    American Board of Internal Medicine, 1981
    Internal Medicine
    American Board of Internal Medicine, 1978

    Education

    Fellowship
    Hematology-Oncology, UCLA School of Medicine, 1982
    Residency
    Internal Medicine, University of Chicago Hospitals, 1979
    Internship
    Internal Medicine, University of Chicago Hospitals, 1976
    Degree
    MD, University of Chicago Pritzker School of Medicine, 1975
  • Clinical Interests
    • Breast
    • Ovarian Cancer
  • Research

    Publications

    UCLA Health System Publications

    Physician Update : Summer 2007 - Oncology
    Clinical Update: March 2007 - Surgical Oncology
    Vital Signs Fall 2005: Breast Cancer Research Explores Promising Treatments

    Link to my PubMed publications.

  • News & Awards

    Awards

    Dr. Slamon has won nearly a dozen national research awards honoring his scientific endeavors.

    In 2000, Slamon was awarded the Translational Medicine Award by the USCD-Salk Institute as well as the Bristol-Myers Squibb Oncology Millennium Award for significant achievement and leadership in breast cancer research.
    In 2001, Slamon was awarded the Wadsworth Center's Brown-Hazen Award for Excellence in the Basic Sciences, and in 2002, he received the Jeffrey A. Gottlieb Memorial Award from the M.D. Anderson Cancer Center in Texas.
    In 2003, Slamon received the Dorothy P. Landon-AACR Prize for Translational Cancer Research, an international award given by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.
    And in 2004, the American Cancer Society presented Slamon with the Medal of Honor, the top award bestowed by the organization.

    Dr. Slamon received the Fifth Aultman Cancer Center Award from Kent State University and the David A. Karnofsky Memorial Award and Lecture at the American Society of Clinical Oncology honoring his work in the development of Herceptin, a molecularly targeted breast cancer therapy. He also received the Warren Alpert Foundation Scientific Prize and the 2007 Gairdner Foundation International Award for his work in the development of Herceptin.